C110H136N36O3 — CID 158385428
1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-[[(3S)-piperidin-3-yl]methylamino]-3-pyridinyl]pyrrolidin-3-ol;(3S)-1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-(piperidin-3-ylmethylamino)-3-pyridinyl]pyrrolidin-3-ol;2-N-(5-ethynylpyrazin-2-yl)-4-N-(1-methylpiperidin-4-yl)-5-pyrrol-1-ylpyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-5-[3-(morpholin-4-ylmethyl)pyrrol-1-yl]-4-N-(piperidin-3-ylmethyl)pyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-4-N-(piperidin-3-ylmethyl)-5-pyrrolidin-1-ylpyridine-2,4-diamine (PubChem CID 158385428) has the molecular formula C110H136N36O3 and a molecular weight of 2010.55 g/mol. Its IUPAC name is 1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-[[(3S)-piperidin-3-yl]methylamino]-3-pyridinyl]pyrrolidin-3-ol;(3S)-1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-(piperidin-3-ylmethylamino)-3-pyridinyl]pyrrolidin-3-ol;2-N-(5-ethynylpyrazin-2-yl)-4-N-(1-methylpiperidin-4-yl)-5-pyrrol-1-ylpyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-5-[3-(morpholin-4-ylmethyl)pyrrol-1-yl]-4-N-(piperidin-3-ylmethyl)pyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-4-N-(piperidin-3-ylmethyl)-5-pyrrolidin-1-ylpyridine-2,4-diamine.
| Compound Name | 1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-[[(3S)-piperidin-3-yl]methylamino]-3-pyridinyl]pyrrolidin-3-ol;(3S)-1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-(piperidin-3-ylmethylamino)-3-pyridinyl]pyrrolidin-3-ol;2-N-(5-ethynylpyrazin-2-yl)-4-N-(1-methylpiperidin-4-yl)-5-pyrrol-1-ylpyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-5-[3-(morpholin-4-ylmethyl)pyrrol-1-yl]-4-N-(piperidin-3-ylmethyl)pyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-4-N-(piperidin-3-ylmethyl)-5-pyrrolidin-1-ylpyridine-2,4-diamine |
|---|---|
| PubChem CID | 158385428 |
| Molecular Formula | C110H136N36O3 |
| Molecular Weight | 2010.55 g/mol |
| Exact Mass | 2009.16 |
| IUPAC Name | 1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-[[(3S)-piperidin-3-yl]methylamino]-3-pyridinyl]pyrrolidin-3-ol;(3S)-1-[6-[(5-ethynylpyrazin-2-yl)amino]-4-(piperidin-3-ylmethylamino)-3-pyridinyl]pyrrolidin-3-ol;2-N-(5-ethynylpyrazin-2-yl)-4-N-(1-methylpiperidin-4-yl)-5-pyrrol-1-ylpyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-5-[3-(morpholin-4-ylmethyl)pyrrol-1-yl]-4-N-(piperidin-3-ylmethyl)pyridine-2,4-diamine;2-N-(5-ethynylpyrazin-2-yl)-4-N-(piperidin-3-ylmethyl)-5-pyrrolidin-1-ylpyridine-2,4-diamine |
| SMILES | C#Cc1cnc(Nc2cc(NC3CCN(C)CC3)c(-n3cccc3)cn2)cn1.C#Cc1cnc(Nc2cc(NCC3CCCNC3)c(-n3ccc(CN4CCOCC4)c3)cn2)cn1.C#Cc1cnc(Nc2cc(NCC3CCCNC3)c(N3CCCC3)cn2)cn1.C#Cc1cnc(Nc2cc(NCC3CCCNC3)c(N3CC[C@H](O)C3)cn2)cn1.C#Cc1cnc(Nc2cc(NC[C@H]3CCCNC3)c(N3CCC(O)C3)cn2)cn1 |
| InChI | InChI=1S/C26H32N8O.2C21H27N7O.C21H23N7.C21H27N7/c1-2-22-15-30-26(17-28-22)32-25-12-23(29-14-20-4-3-6-27-13-20)24(16-31-25)34-7-5-21(19-34)18-33-8-10-35-11-9-33;2*1-2-16-11-25-21(13-23-16)27-20-8-18(24-10-15-4-3-6-22-9-15)19(12-26-20)28-7-5-17(29)14-28;1-3-16-13-23-21(15-22-16)26-20-12-18(25-17-6-10-27(2)11-7-17)19(14-24-20)28-8-4-5-9-28;1-2-17-13-25-21(15-23-17)27-20-10-18(24-12-16-6-5-7-22-11-16)19(14-26-20)28-8-3-4-9-28/h1,5,7,12,15-17,19-20,27H,3-4,6,8-11,13-14,18H2,(H2,29,30,31,32);2*1,8,11-13,15,17,22,29H,3-7,9-10,14H2,(H2,24,25,26,27);1,4-5,8-9,12-15,17H,6-7,10-11H2,2H3,(H2,23,24,25,26);1,10,13-16,22H,3-9,11-12H2,(H2,24,25,26,27)/t;15?,17-;15-,17?;;/m.00../s1 |
| InChIKey | GWHRKFCDOZAKGQ-ZYCQIMBDSA-N |
| XLogP | 11.29 |
| TPSA | 437.52 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 39 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 149 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2010.55 |
| LogP ≤ 5 | 11.29 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 39 |
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|